Cargando…

Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting

BACKGROUND: Skeletal muscle wasting (SMW) in cancer patients is associated with increased morbidity, mortality, treatment intolerance and discontinuation, and poor quality of life. This is particularly true for patients with pancreatic ductal adenocarcinoma (PDAC), as over 85% experience SMW, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Cole, Calvin L., Bachman, John F., Ye, Jian, Murphy, Joseph, Gerber, Scott A., Beck, Christopher A., Boyce, Brendan F., Muthukrishnan, Gowrishankar, Chakkalakal, Joe V., Schwarz, Edward M., Linehan, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200439/
https://www.ncbi.nlm.nih.gov/pubmed/33960737
http://dx.doi.org/10.1002/jcsm.12699
_version_ 1783707603017138176
author Cole, Calvin L.
Bachman, John F.
Ye, Jian
Murphy, Joseph
Gerber, Scott A.
Beck, Christopher A.
Boyce, Brendan F.
Muthukrishnan, Gowrishankar
Chakkalakal, Joe V.
Schwarz, Edward M.
Linehan, David
author_facet Cole, Calvin L.
Bachman, John F.
Ye, Jian
Murphy, Joseph
Gerber, Scott A.
Beck, Christopher A.
Boyce, Brendan F.
Muthukrishnan, Gowrishankar
Chakkalakal, Joe V.
Schwarz, Edward M.
Linehan, David
author_sort Cole, Calvin L.
collection PubMed
description BACKGROUND: Skeletal muscle wasting (SMW) in cancer patients is associated with increased morbidity, mortality, treatment intolerance and discontinuation, and poor quality of life. This is particularly true for patients with pancreatic ductal adenocarcinoma (PDAC), as over 85% experience SMW, which is responsible for ~30% of patient deaths. While the established paradigm to explain SMW posits that muscle catabolism from systemic inflammation and nutritional deficiencies, the cause of death, and the cellular and molecular mechanisms responsible remain to be elucidated. To address this, we investigated the relationship between tumour burden and survival in the KCKO murine PDAC model. METHODS: Female C57BL/6J mice 6–8 weeks of age underwent orthotopic injection with KCKO‐luc tumour cells. Solid tumour was verified on Day 5, post‐tumour inoculation. In vivo, longitudinal lean mass and tumour burden were assessed via dual‐energy X‐ray absorptiometry and IVIS imaging, respectively, and total body weight was assessed, weekly. Animals were sacrificed at a designated end point of ‘failure to thrive’. After sacrifice, lower limb hind muscles were harvested for histology and RNA extraction. RESULTS: We found a strong correlation between primary tumour size and survival (r (2) = 0.83, P < 0.0001). A significant decrease in lower limb lean mass was first detected at Day 38 post‐implantation vs. no tumour controls (NTCs) (P < 0.0001). SMW was confirmed by histology, which demonstrated a 38%, 32.7%, and 39.9% decrease in fibre size of extensor digitorum longus, soleus, and tibialis anterior muscles, respectively, in PDAC mice vs. NTC (P < 0.002). Histology also revealed a 67.6% increase in haematopoietic cells within the muscle of PDAC mice when compared with NTC. Bulk RNAseq on muscles from PDAC mice vs. NTC revealed significant increases in c/ebpβ/Δ, il‐1, il‐6, and tnf gene expression. Pathway analyses to identify potential upstream factors revealed increased adipogenic gene expression, including a four‐fold increase in igfbp‐3. Histomorphometry of Oil Red‐O staining for fat content in tibialis anterior muscles demonstrated a 95.5% increase in positively stained fibres from PDAC mice vs. NTC. CONCLUSIONS: Together, these findings support a novel model of PDAC‐associated SMW and mortality in which systemic inflammation leads to inflammatory cell infiltration into skeletal muscle with up‐regulated myocellular lipids.
format Online
Article
Text
id pubmed-8200439
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82004392021-06-15 Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting Cole, Calvin L. Bachman, John F. Ye, Jian Murphy, Joseph Gerber, Scott A. Beck, Christopher A. Boyce, Brendan F. Muthukrishnan, Gowrishankar Chakkalakal, Joe V. Schwarz, Edward M. Linehan, David J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Skeletal muscle wasting (SMW) in cancer patients is associated with increased morbidity, mortality, treatment intolerance and discontinuation, and poor quality of life. This is particularly true for patients with pancreatic ductal adenocarcinoma (PDAC), as over 85% experience SMW, which is responsible for ~30% of patient deaths. While the established paradigm to explain SMW posits that muscle catabolism from systemic inflammation and nutritional deficiencies, the cause of death, and the cellular and molecular mechanisms responsible remain to be elucidated. To address this, we investigated the relationship between tumour burden and survival in the KCKO murine PDAC model. METHODS: Female C57BL/6J mice 6–8 weeks of age underwent orthotopic injection with KCKO‐luc tumour cells. Solid tumour was verified on Day 5, post‐tumour inoculation. In vivo, longitudinal lean mass and tumour burden were assessed via dual‐energy X‐ray absorptiometry and IVIS imaging, respectively, and total body weight was assessed, weekly. Animals were sacrificed at a designated end point of ‘failure to thrive’. After sacrifice, lower limb hind muscles were harvested for histology and RNA extraction. RESULTS: We found a strong correlation between primary tumour size and survival (r (2) = 0.83, P < 0.0001). A significant decrease in lower limb lean mass was first detected at Day 38 post‐implantation vs. no tumour controls (NTCs) (P < 0.0001). SMW was confirmed by histology, which demonstrated a 38%, 32.7%, and 39.9% decrease in fibre size of extensor digitorum longus, soleus, and tibialis anterior muscles, respectively, in PDAC mice vs. NTC (P < 0.002). Histology also revealed a 67.6% increase in haematopoietic cells within the muscle of PDAC mice when compared with NTC. Bulk RNAseq on muscles from PDAC mice vs. NTC revealed significant increases in c/ebpβ/Δ, il‐1, il‐6, and tnf gene expression. Pathway analyses to identify potential upstream factors revealed increased adipogenic gene expression, including a four‐fold increase in igfbp‐3. Histomorphometry of Oil Red‐O staining for fat content in tibialis anterior muscles demonstrated a 95.5% increase in positively stained fibres from PDAC mice vs. NTC. CONCLUSIONS: Together, these findings support a novel model of PDAC‐associated SMW and mortality in which systemic inflammation leads to inflammatory cell infiltration into skeletal muscle with up‐regulated myocellular lipids. John Wiley and Sons Inc. 2021-05-07 2021-06 /pmc/articles/PMC8200439/ /pubmed/33960737 http://dx.doi.org/10.1002/jcsm.12699 Text en © 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Cole, Calvin L.
Bachman, John F.
Ye, Jian
Murphy, Joseph
Gerber, Scott A.
Beck, Christopher A.
Boyce, Brendan F.
Muthukrishnan, Gowrishankar
Chakkalakal, Joe V.
Schwarz, Edward M.
Linehan, David
Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting
title Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting
title_full Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting
title_fullStr Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting
title_full_unstemmed Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting
title_short Increased myocellular lipid and IGFBP‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting
title_sort increased myocellular lipid and igfbp‐3 expression in a pre‐clinical model of pancreatic cancer‐related skeletal muscle wasting
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200439/
https://www.ncbi.nlm.nih.gov/pubmed/33960737
http://dx.doi.org/10.1002/jcsm.12699
work_keys_str_mv AT colecalvinl increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT bachmanjohnf increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT yejian increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT murphyjoseph increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT gerberscotta increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT beckchristophera increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT boycebrendanf increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT muthukrishnangowrishankar increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT chakkalakaljoev increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT schwarzedwardm increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting
AT linehandavid increasedmyocellularlipidandigfbp3expressioninapreclinicalmodelofpancreaticcancerrelatedskeletalmusclewasting